Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News TACTI-004 investigation gives Immutep a possible explanation as efti prepares for 2027 restart Immutep finds efti manufacturing differences after TACTI-004 and refocuses development on head and neck cancer and soft tissue sarcoma. bySoujanya RaviSeptember 14, 2026